Skip to main content
HR 2802 109th Congress House Crime and Law Enforcement Commerce Drug abuse Drug testing Fraud Restrictive trade practices

Drug Testing Integrity Act of 2005

Introduced: June 8, 2005 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 17, 2005
Referred to the Subcommittee on Commerce, Trade and Consumer Protection.
Jun 8, 2005
Referred to the House Committee on Energy and Commerce.
Jun 8, 2005
Introduced in House
 Plain-English summary Congressional Research Service

Drug Testing Integrity Act of 2005 - Declares it is unlawful to: (1) knowingly manufacture, market, sell, ship, or otherwise provide to another individual any product with the intent to assist the use of such product to defraud a drug test (that is, to submit a substance that purports to be from an individual other than its actual source, or purports to have been excreted or collected other than when it was actually excreted or collected); or (2) engage in any other conduct with the intent to produce a false or misleading outcome of a test for the presence of a controlled substance.

Grants the Federal Trade Commission enforcement powers as a violation of an unfair or deceptive act or practice.

What's happening now June 17, 2005

Referred to the Subcommittee on Commerce, Trade and Consumer Protection.

 Committees of jurisdiction 2
 Cosponsors 1
All 1 Democratic 1